iCAD, Inc. (NASDAQ:ICAD) Short Interest Update

iCAD, Inc. (NASDAQ:ICAD) was the target of a large growth in short interest in September. As of September 15th, there was short interest totalling 196,800 shares, a growth of 7.6% from the August 31st total of 182,900 shares. Based on an average daily volume of 170,500 shares, the days-to-cover ratio is currently 1.2 days. Approximately 0.8% of the company’s stock are sold short.

iCAD Price Performance

Shares of NASDAQ:ICAD opened at $1.53 on Wednesday. iCAD has a 12 month low of $1.18 and a 12 month high of $2.65. The firm has a market capitalization of $40.61 million, a P/E ratio of -12.75 and a beta of 1.51. The company’s fifty day moving average price is $1.48 and its 200 day moving average price is $1.49.

iCAD (NASDAQ:ICAD) last issued its quarterly earnings data on Tuesday, August 13th. The technology company reported ($0.07) earnings per share (EPS) for the quarter. The business had revenue of $5.03 million for the quarter. iCAD had a negative return on equity of 13.59% and a negative net margin of 15.67%.

Institutional Trading of iCAD

Institutional investors have recently added to or reduced their stakes in the stock. Salem Investment Counselors Inc. acquired a new position in iCAD during the first quarter worth about $119,000. AMH Equity Ltd acquired a new position in iCAD during the first quarter worth about $207,000. First Eagle Investment Management LLC raised its position in iCAD by 3.2% during the first quarter. First Eagle Investment Management LLC now owns 701,525 shares of the technology company’s stock worth $1,129,000 after acquiring an additional 22,000 shares during the last quarter. Perritt Capital Management Inc. raised its position in iCAD by 7.5% during the first quarter. Perritt Capital Management Inc. now owns 139,983 shares of the technology company’s stock worth $225,000 after acquiring an additional 9,717 shares during the last quarter. Finally, Virtu Financial LLC raised its position in iCAD by 55.6% during the first quarter. Virtu Financial LLC now owns 21,286 shares of the technology company’s stock worth $34,000 after acquiring an additional 7,604 shares during the last quarter. Hedge funds and other institutional investors own 24.61% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, StockNews.com upgraded shares of iCAD from a “sell” rating to a “hold” rating in a research note on Thursday, August 22nd.

About iCAD

iCAD, Inc engages in the provision of cancer detection and therapy solutions in the United States. It operates through two segments, Detection and Therapy. The company provides ProFound AI for digital breast tomosynthesis and 2D mammography; PowerLook, a density assessment solution; and ProFound Risk, a breast cancer risk analysis.